Sciton MOXI

Name: Sciton MOXI
Brand: Sciton

Non-Ablative Fractional · 1927nm fractional diode

Work at Sciton? — one claim covers all 13 of your devices.

CurrentFDA ClearedBe the first to review

Sciton MOXI pricing is not published by the manufacturer, and we have not yet verified a US market range. Sciton MOXI holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.

What it's actually cleared for: 1927nm fractional diode cleared for non-ablative resurfacing treating pigmentation, tone and texture

Last verified: August 6, 2026 · How we verify

New: —|Used: —market estimate, no email required

Key facts
Manufacturer	Sciton
Company	Owner: Employee-owned (co-founders James Hobart and Daniel Negus) (family / founder owned, since 1997) · Distribution: direct
Category	Resurfacing, Tattoo & Vascular
Technology	1927nm fractional diode
FDA status	FDA Cleared
New price range	Not published
Used price range	Not published
Consumables	Not published
Launch year	2020
Last verified	August 6, 2026

Save device

Bottom line

The smartest patient-acquisition laser of the decade: a gentle 1927nm fractional treatment marketed as "prejuvenation" that gets 25-35-year-olds onto your table years before they'd consider anything ablative. Safe on virtually all skin types year-round, takes 15-30 minutes, and has almost no consumable cost. It will not replace a resurfacing laser and margins depend on volume and memberships, not big tickets. Buy it (usually on the mJOULE paired with BBL HERO) as a funnel-builder, not a hero device.

Overview

Prejuvenation/melasma module on mJoule/Joule

How it works

The science

A 1927nm fractionated diode laser — strongly absorbed by water, creating microscopic columns of coagulated (not vaporized) tissue in the upper dermis. The skin exchanges damaged, pigmented cells for fresh ones over about a week of light "coffee-ground" flaking. Improves tone, early sun damage, melasma-prone pigmentation and texture; because it's non-ablative and melanin-conservative it's workable on Fitzpatrick IV-VI where IPL is risky. Three intensity levels scale from lunchtime glow-up to a more corrective pass.

Patented tech

No exotic proprietary physics — the value is Sciton's dose control and the mJOULE pairing; "prejuvenation" is a marketing framework. Comparable wavelength class to Clear + Brilliant Permea and LaseMD, with MOXI generally the more powerful.

Origin

Palo Alto, California.

FDA & regulatory status

FDA ClearedAuthorized via 510(k)

What it's actually cleared for:

1927nm fractional diode cleared for non-ablative resurfacing treating pigmentation, tone and texture

510(k) numbers

K213350; K222958

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Treatment economics

What practices charge

~$500-800 standalone, commonly a series of 3 (~$1,400-2,000) or "MOXI + BBL" combos at ~$800-1,200 per visit; memberships ~$150-300/month increasingly common. Quarterly maintenance is the intended cadence.

Consumables & recurring cost

Essentially none — ongoing cost is basically zinc oxide and numbing cream. Per-treatment margin among the best in energy-based aesthetics.

Ideal for

Best-fit practice

High-volume medspas with a younger, social-media-driven clientele and a membership engine; also practices with heavy Fitzpatrick IV-VI demographics needing a pigment-safe laser. If your book is 55+ patients wanting one big correction, wrong tool.

Compliance

Medical director & delegation

Class II prescription laser; routinely delegated to RNs and, in permissive states, laser-certified aestheticians under medical direction — state rules vary widely.

Contraindications & screening

Pregnancy, recent isotretinoin, active infection; manage melasma expectations (helps but recurs); herpes prophylaxis for perioral treatment.

Ownership

Warranty & service

1-year standard with Sciton's strong US network; extended ~$8K-15K/year for an mJOULE.

Resale & used market

Strong — mJOULE (MOXI + BBL HERO) units in high demand used at ~$70K-120K and move quickly; standalone MOXI rarer on the secondary market.

Chains using this device

No confirmed chain deployments recorded yet.

Owner reviews

Write a review

No verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.